학술논문
Subcutaneous epcoritamab with rituximab plus lenalidomide (R2) in patients (pts) with relapsed or refractory (R/R) follicular lymphoma (FL): Update from phase 1/2 trial.
Document Type
ConferencePaper
Author
Source
JOURNAL OF CLINICAL ONCOLOGY. 40(16)
Subject
Language
English
English
English
ISSN
0732-183X